RoslinCT and Lykan Bioscience Combine to Create Leading Advanced Cell Therapy CDMO

RoslinCT, a cell and gene therapy Contract Development and Manufacturing Organisation (‘CDMO’), and Lykan Bioscience, an innovative CDMO focused on cell-based therapies, announced that they have entered into a business combination agreement to form a global leading innovative advanced therapies CDMO.